CAS RN: 38521-51-6
2,3,4,5,6-PENTABROMOBENZYL BROMIDE
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250829
100mg / 250mg / 500mg
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 38521-51-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Beijing
Inquiry
38521-51-6 / 1,2,3,4,5-pentabromo-6-(bromomethyl)benzene
Standard CAS: 38521-51-6
Multi CAS: No
Basic Information
copy
CAS
38521-51-6 copy
Multi CAS
No copy
Molecular Formula
C7H2BR6 copy
Molecular Weight
565.500000 copy
Exact Mass
565.519530 copy
InChI
InChI=1S/C7H2Br6/c8-1-2-3(9)5(11)7(13)6(12)4(2)10/h1H2 copy
InChIKey
PYOIYKRKAHYOKO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.14 copy
Rotatable bonds
1 copy
Molar refractivity
77.57 copy
TPSA
0.0000 copy
LogP / Solubility
WLOGP
6.39 copy
MLOGP
5.67 copy
XLogP3
5.9 copy
Consensus LogP
5.99 copy
Log S (ESOL)
-7.65 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-8.81 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-8.76 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.63 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy